More on REC
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $20.06 |
|
|||
| Open | $13.07 | ||||
| 52 Wk High | $10.16 | ||||
| 52 Wk Low | $4.25 | ||||
| Day High | $20.06 | ||||
| Day Low | $20.06 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 572,471 | ||||
- RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
- Recordati partners with Moderna on rare disease treatment mRNA-3927
- RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
- Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
- ReconAfrica Announces Strategic Entry into Offshore Gabon and Signing of a Production Sharing Contract that Adds Significant Oil Appraisal, Development and Exploration Opportunities
- Soundcoat Unveils Renovated Acoustics Lab, Reflecting the Company's Engineering Excellence
- EnerCom Announces Liberty Energy and Baker Hughes as Keynote Speakers at the 30th Annual EnerCom Denver - The Energy Investment Conference
Entities mentioned with REC
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- CVC Capital Partners | View Related Stories »
- Citi | View Related Stories »
- Crude Oil | View Related Stories »
- Show More...
